It's no secret that branded drugmakers often rely on price hikes to keep U.S. sales growth coming, especially on older meds whose patents are close to the ends of their lives. But according to new data, prices spiked more than 10% last year--a trend that may fuel the payer backlash that's been steadily mounting.
U.S. consumers saw prescription med prices vault 10.9% in 2014, according to the Truveris National Drug Index. Branded drug prices soared the most, climbing by 14.8%. But specialty drugs contributed their fair share to the leap, rising by 9.7%, and even generics chipped in with a 4.9% price jump.Read more